Evaluation – 20220606 – Abbott Laboratories Inc – Industry Workshop Session Title: Saving lives using high sensitivity troponin-I with best practice examples of mitigated cardiovascular risk and death associated with post-operative care following cardiac surgery as well as routine Annual Health Assessments. Presenters: Andre Lamy, Cardiac Surgeon, Hamilton Health Sciences Professor, Department of Surgery, McMaster University Peter Nord, Chief Medical Officer, Medcan Tricia Ravalico, Director of Global Scientific Leadership and Education, Abbott Laboratories Objectives: At the conclusion of this session, participants will be able to explain and apply: Recognize the prognostic power of hsTn-I for enhanced cardiovascular risk mitigation in settings outside of acute myocardial infarction Understand landmark findings from the recently published CARDIAC VISION study including expected changes in upcoming recommendations related to relevant thresholds for the application of hsTnI for the detection of perioperative myocardial infarction and clinically important perioperative myocardial injury. Highlight the substantial benefits of cardiac health screening for patients, payors, clinicians and the health ecosystem via strategic implementation of high-sensitivity troponin-I for measurably better healthcare. 1. Please rate the Session by choosing the appropriate number: Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly AgreeSufficient time was allowed for audience participation/active learning. One Two Three Four Five The facilities were satisfactory. One Two Three Four Five The session was free from commercial bias. One Two Three Four Five Overall, I would rate this Symposium as excellent. One Two Three Four Five 2. Please assess the Speaker by choosing the appropriate number: Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree Andre Lamy, Cardiac Surgeon, Hamilton Health Sciences Professor, Department of Surgery, McMaster UniversityClarity of One Two Three Four Five Met Stated Objectives One Two Three Four Five Balanced & Unbiased One Two Three Four Five Relevant to Practice Overall One Two Three Four Five Time for Active Learning One Two Three Four Five 3. Please assess the Speaker by choosing the appropriate number. Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree Peter Nord, Chief Medical Officer, Medcan Clarity of One Two Three Four Five Met Stated Objectives One Two Three Four Five Balanced & Unbiased One Two Three Four Five Relevant to Practice Overall One Two Three Four Five Time for Active Learning One Two Three Four Five 3. Please asses the Speaker by circling the appropriate number. Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree Tricia Ravalico, Director of Global Scientific Leadership and Education, Abbott Laboratories Clarity of One Two Three Four Five Met Stated Objectives One Two Three Four Five Balanced & Unbiased One Two Three Four Five Relevant to Practice Overall One Two Three Four Five Time for Active Learning One Two Three Four Five 4. As a result of attending this session, I am planning to: (please check one)a) Discuss the session with my colleagues Yes No b) Pursue additional learning activities. Yes No c) Complete a Personal Learning Project. Yes No d) Not change my practice. Yes No 3) Change my practice. Yes No 5. Please explain the change you are planning to make or the learning you plan to complete:6. Please indicate which CanMEDS roles you felt were addressed during this educational activity. (Select all that apply) Medical Expert Communicator Collaborator Manager Health Advocate Scholar Professional 7. General comments about individual speakers8. What topics need to be addressed at future conferences to keep you up to date in your profession?Name Session Title Date Year Location Conference/Event CreditsEmail Session Code
